Ramirez Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$390K Sell
9,129
-7
-0.1% -$380 0.04% 174
2026
Q1
$573K Sell
9,136
-700
-7% -$56K 0.07% 154
2025
Q4
$938K Hold
9,836
0.12% 145
2025
Q3
$960K Hold
9,836
0.13% 145
2025
Q2
$1.06M Sell
9,836
-100
-1% -$10.1K 0.16% 134
2025
Q1
$1M Sell
9,936
-5,899
-37% -$594K 0.21% 127
2024
Q4
$1.41M Hold
15,835
0.29% 103
2024
Q3
$1.33M Hold
15,835
0.25% 108
2024
Q2
$1.22M Buy
15,835
+63
+0.4% +$4.61K 0.25% 111
2024
Q1
$1.08M Buy
15,772
+5,642
+56% +$363K 0.22% 123
2023
Q4
$586K Sell
10,130
-3,591
-26% -$192K 0.12% 161
2023
Q3
$724K Buy
+13,721
New +$720K 0.16% 144

Other funds holding BSX

Ramirez Asset Management's BSX Position: Q2 2026 in Review

Ramirez Asset Management reduced its Boston Scientific (BSX) stake by 0.08% in Q2 2026, selling an estimated $380 and leaving 9,129 shares worth $390K. The position accounts for 0.04% of the portfolio, ranked #174.

Ramirez Asset Management first reported a position in BSX in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.41M in Q4 2024. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Ramirez Asset Management held 9,129 shares of Boston Scientific worth $390K as of Q2 2026.
  • Ramirez Asset Management sold 7 Boston Scientific shares in Q2 2026, an estimated $380.
  • Boston Scientific made up 0.04% of Ramirez Asset Management's portfolio in Q2 2026, its #174 holding.
  • Ramirez Asset Management first reported a position in Boston Scientific in Q3 2023 and has held it in 12 quarters since.
  • Ramirez Asset Management's Boston Scientific position peaked at $1.41M in Q4 2024.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Ramirez Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.